DE60236084D1 - Perkutan resorbierbare pflaster - Google Patents

Perkutan resorbierbare pflaster

Info

Publication number
DE60236084D1
DE60236084D1 DE60236084T DE60236084T DE60236084D1 DE 60236084 D1 DE60236084 D1 DE 60236084D1 DE 60236084 T DE60236084 T DE 60236084T DE 60236084 T DE60236084 T DE 60236084T DE 60236084 D1 DE60236084 D1 DE 60236084D1
Authority
DE
Germany
Prior art keywords
percutane
resorbable
plaster
salt
inflammatory agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236084T
Other languages
English (en)
Inventor
Y Takada
K Tanaka
T Kurita
Y Ikeura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of DE60236084D1 publication Critical patent/DE60236084D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60236084T 2001-05-31 2002-05-02 Perkutan resorbierbare pflaster Expired - Lifetime DE60236084D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001164065 2001-05-31
PCT/JP2002/004382 WO2002098396A1 (fr) 2001-05-31 2002-05-02 Timbres a absorption par voie percutanee

Publications (1)

Publication Number Publication Date
DE60236084D1 true DE60236084D1 (de) 2010-06-02

Family

ID=19006932

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236084T Expired - Lifetime DE60236084D1 (de) 2001-05-31 2002-05-02 Perkutan resorbierbare pflaster

Country Status (13)

Country Link
US (1) US20040146548A1 (de)
EP (1) EP1400240B1 (de)
JP (1) JP4627985B2 (de)
KR (2) KR20090037983A (de)
CN (1) CN1253149C (de)
AT (1) ATE464887T1 (de)
BR (1) BRPI0210074B1 (de)
CA (1) CA2448689C (de)
DE (1) DE60236084D1 (de)
ES (1) ES2343168T3 (de)
HK (1) HK1060842A1 (de)
PT (1) PT1400240E (de)
WO (1) WO2002098396A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034374B2 (en) * 2003-03-18 2011-10-11 Hisamitsu Pharmaceutical Co., Inc. Patch containing nonsteroidal anti-inflammatory and analgesic agent
EP1652523A4 (de) * 2003-08-04 2008-11-19 Kyorin Seiyaku Kk Transdermales absorptionspräparat
TWI341736B (en) * 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations
EP1773414A1 (de) * 2004-07-08 2007-04-18 Alltracel Development Services Limited Abgabesystem zur kontrolle der blutung von hautwunden
JP5117846B2 (ja) * 2005-02-25 2013-01-16 久光製薬株式会社 抗炎症剤及び大豆レシチンを含有する外用剤
EP1854456B1 (de) * 2005-02-28 2017-08-23 Hisamitsu Pharmaceutical Co., Inc. Haftklebstoffbasis und medizinisches klebepflaster mit der haftklebstoffbasis
WO2006118173A1 (ja) * 2005-04-28 2006-11-09 Ono Pharmaceutical Co., Ltd. 経皮吸収製剤
CN100420726C (zh) * 2005-09-19 2008-09-24 上海安立霸电器有限公司 医用热熔压敏胶型基质及制备
JP4869697B2 (ja) * 2005-12-08 2012-02-08 日東電工株式会社 外用剤
JP5015562B2 (ja) * 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
JP5075378B2 (ja) * 2006-09-08 2012-11-21 久光製薬株式会社 貼付剤製品
EP2116234A4 (de) * 2006-12-06 2012-01-18 Nipro Patch Co Ltd Pharmazeutische zusammensetzung zur externen applikation und hautklebepflaster
EP2143445B1 (de) * 2007-04-23 2013-09-04 Hisamitsu Pharmaceutical Co., Inc. Mit arzneistoff versetztes pflaster
EA018119B1 (ru) * 2007-06-08 2013-05-30 Троикаа Фармасьютикалз Лтд. Новый неводный раствор диклофенака для местного применения и способ его получения
JP2009280509A (ja) * 2008-05-20 2009-12-03 Kowa Co 鎮痛・抗炎症剤含有外用剤
KR100922519B1 (ko) 2008-11-12 2009-10-20 대원제약주식회사 펠루비프로펜을 함유하는 용출률 및 안정성이 개선된 경구투여용 약제학적 제제
JP5421063B2 (ja) * 2009-10-23 2014-02-19 帝國製薬株式会社 ジクロフェナクナトリウム含有水性貼付剤
CA2815792C (en) * 2010-11-02 2019-01-08 Teikoku Seiyaku Co., Ltd. Felbinac-containing external patch
JP6131523B2 (ja) * 2011-03-25 2017-05-24 大正製薬株式会社 ロキソプロフェン含有外用剤
JP5878715B2 (ja) * 2011-09-22 2016-03-08 久光製薬株式会社 貼付剤
US20150231255A1 (en) * 2012-06-20 2015-08-20 Hisamitsu Pharmaceutical Co., Inc. Absorption promoting agent and patch comprising same
EP2968652B1 (de) 2013-03-13 2020-07-22 Avery Dennison Corporation Verbesserung von hafteigenschaften
CN105228577B (zh) * 2013-03-15 2018-07-10 厄耳他拉登脱产品股份有限公司 稳定的牙漆组合物及其制备方法和应用
EP3206673B1 (de) * 2014-10-17 2024-08-21 Fidia Farmaceutici S.p.A. System zur dermalen therapie mit hoher haftbarkeit
JP6304457B2 (ja) * 2015-08-27 2018-04-04 東洋インキＳｃホールディングス株式会社 貼付剤
KR102200892B1 (ko) * 2019-05-13 2021-01-12 대원제약주식회사 펠루비프로펜의 신규 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
CN110169960B (zh) * 2019-07-04 2022-10-04 山东理工大学 热熔压敏胶型经皮给药贴及其制备方法
JP6761553B1 (ja) * 2020-02-12 2020-09-23 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
JP6744511B1 (ja) * 2020-02-12 2020-08-19 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物
KR102552315B1 (ko) * 2020-11-11 2023-07-06 대원제약주식회사 펠루비프로펜 신규 염을 주성분으로 하며 위장장애 부작용이 저감된 약학적 조성물
KR102462607B1 (ko) * 2020-11-11 2022-11-03 대원제약주식회사 펠루비프로펜 신규 염을 주성분으로 하는 안정성이 증가된 약학적 조성물
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS5933211A (ja) * 1982-08-20 1984-02-23 Sato Seiyaku Kk 油性軟膏
JPS59164714A (ja) * 1983-03-09 1984-09-17 Sekisui Chem Co Ltd 治療用接着テ−プもしくはシ−ト
JPS59164715A (ja) * 1983-03-09 1984-09-17 Nitto Electric Ind Co Ltd 外用部材の製法
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
JPS6112621A (ja) * 1984-06-27 1986-01-21 Lion Corp パツプ剤
JPS61260026A (ja) * 1985-05-14 1986-11-18 Showa Denko Kk 経皮吸収性を高めた皮膚外用剤
EP0189861A3 (de) * 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Transdermaler Absorptionsbeschleuniger für ionische wasserlösliche Arzneistoffe
EP0267617B1 (de) * 1986-11-14 1992-06-24 Theratech, Inc. Erhöhung des Penetrationsvermögens mittels eines aus die Zellhülle verändernden Substanzen und kurzkettigen Alkoholen bestehenden binären Systems
JP2572763B2 (ja) * 1987-04-02 1997-01-16 帝國製薬株式会社 エトフェナマ−ト含有貼付薬
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
JPH04217925A (ja) * 1990-03-27 1992-08-07 Nippon Saafuakutanto Kogyo Kk 新規な解熱消炎鎮痛剤組成物
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
JP3226940B2 (ja) * 1990-05-30 2001-11-12 山之内製薬株式会社 経皮投与製剤
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
ATE176153T1 (de) * 1991-08-30 1999-02-15 Hisamitsu Pharmaceutical Co Entzündungshemmendes, analgetisches pflaster
JP2653592B2 (ja) * 1991-12-04 1997-09-17 救急薬品工業株式会社 非ステロイド系薬物高放出性テープ剤
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
JP2569396B2 (ja) * 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
EP0788794A4 (de) * 1994-08-09 2000-06-28 Tsumura & Co Mittel zur externen anwendung
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
EP0879597A4 (de) * 1996-02-07 2001-01-31 Tsumura & Co Transparente wässrige lösung von natrium diclofenac und arzneimittel unter deren verwendung
JPH09208463A (ja) * 1996-02-07 1997-08-12 Tsumura & Co 経皮吸収性に優れた消炎鎮痛組成物
JPH09208542A (ja) * 1996-02-07 1997-08-12 Tsumura & Co ジクロフェナクナトリウムの透明水溶液
JP2001517493A (ja) * 1997-09-26 2001-10-09 ノーヴェン ファーマシューティカルズ インコーポレイテッド 生体接着剤組成物及び活性薬剤の局所投与方法
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
JPH11222443A (ja) * 1997-11-11 1999-08-17 Saitama Daiichi Seiyaku Kk 経皮吸収促進組成物および経皮吸収製剤
CN1361686A (zh) * 1999-07-15 2002-07-31 久光制药株式会社 经皮吸收制剂
EP1217975A1 (de) * 1999-09-08 2002-07-03 Watson Pharmaceuticals, Inc. Verwendung von quartären ammoniumsalzen zur transdermalen applikation von arzneimitteln
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers

Also Published As

Publication number Publication date
PT1400240E (pt) 2010-06-18
US20040146548A1 (en) 2004-07-29
CA2448689C (en) 2009-09-01
JPWO2002098396A1 (ja) 2004-09-16
EP1400240B1 (de) 2010-04-21
ATE464887T1 (de) 2010-05-15
JP4627985B2 (ja) 2011-02-09
CA2448689A1 (en) 2002-12-12
HK1060842A1 (en) 2004-08-27
WO2002098396A1 (fr) 2002-12-12
EP1400240A4 (de) 2006-06-28
BR0210074A (pt) 2004-06-22
BRPI0210074B1 (pt) 2017-05-30
ES2343168T3 (es) 2010-07-26
KR20090037983A (ko) 2009-04-16
EP1400240A1 (de) 2004-03-24
KR20040002890A (ko) 2004-01-07
CN1253149C (zh) 2006-04-26
CN1511027A (zh) 2004-07-07

Similar Documents

Publication Publication Date Title
DE60236084D1 (de) Perkutan resorbierbare pflaster
DK1477164T3 (da) Perkutant plaster af absorptionstypen
DE60234409D1 (de) Säuregenerator, Sulfonsäure, Sulfonsäurederivate und strahlungsempfindliche Zusammensetzung
ATE449079T1 (de) Pharmazeutische zusammensetzungen beinhaltend kristallsalze von 7-ä4-(4-fluorophenyl)-6- isopropyl-2-
EE200300190A (et) Arüül- või heteroarüülkondenseerunud imidasooliühendid põletikuvastaste ja analgeetiliste ainetena
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
NO980553L (no) Endotelinantagonist
DE50212273D1 (de) Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen
WO2007062347A3 (en) Foamed substrate and method for making same
ATE153853T1 (de) Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
ATE333264T1 (de) Wässrige kosmetische zusammensetzung mit verbesserter stabilität
ATE293630T1 (de) Combretastatine a-4 phosphate prodrug salze mit stickstoff-enthaltenden verbindungen
DK0974350T3 (da) Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette
DK1082109T3 (da) Oral formulering omfattende biguanid og en organisk syre
IS2399B (is) Aðferðir til að framleiða 2-(N-metýl-N-metansúlfónýlamínó)pýrimidín, hýdroxýpýrimidín, halógenpýrimidín eða lífrænar súlfónýloxýpýrimidín afleiður ogefnasambönd sem fást með þeim
YU33602A (sh) Rastvori koji sadrže epinastin
FI19991703A (fi) Menetelmä ammoniakkipitoisen vesiliuoksen haihduttamiseksi
IT1312115B1 (it) Composti amorfi e relative composizioni farmaceutiche
ATE446020T1 (de) Calcium-aufnahme verstärker
DE69521734D1 (de) Perkutane Zubereitung enthaltend Tulobuterol
EE05113B1 (et) Adhesiivssteem, k?vendi kompositsioon, nende kasutamine ja nende pealekandmismeetodid
ES2431085T8 (es) Uso de glutamato, derivados o metabolitos de glutamato, análogos de glutamato o mezclas de los mismos para la fabricación de una composición para el tratamiento de osteoporosis
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE259813T1 (de) Triazolopyrimidinderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition